CORC

浏览/检索结果: 共30条,第1-10条 帮助

限定条件        
已选(0)清除 条数/页:   排序方式:
Superconducting ECR ion source: From 24-28 GHz SECRAL to 45 GHz fourth generation ECR 会议论文
作者:  Wu, W.;  Sun, L. T.;  Guo, J. W.;  Zhang, W. H.;  Xie, D. Z.
收藏  |  浏览/下载:37/0  |  提交时间:2018/08/20
A China-manufactured bevacizumab biosimilar, HLX04, matches bevacizumab sourced from China, USA and the European Union 会议论文
作者:  Ding, Y.;  Yu, T.;  Sun, J.;  Wu, M.;  Chen, Q.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) in patients with refractory/metastatic nasopharyngeal carcinoma: Preliminary results of an open-label phase II clinical study 会议论文
作者:  Xu, R.;  Wang, F. H.;  Feng, F. J.;  Li, Q.;  Xu, N.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Clinical Characterization of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers 会议论文
作者:  Hu, Y.;  Liu, Z.;  Wu, L.;  Cao, J.;  Yang, Z.
收藏  |  浏览/下载:33/0  |  提交时间:2019/12/05
Preliminary safety, pharmacokinetics (PK) and efficacy results from a phase I study of CS1001, an anti-programmed death ligand-1 (PD-L1) monoclonal antibody (mAb) in patients (pts) with advanced tumors 会议论文
作者:  Shen, L.;  Cao, J.;  Gong, J.;  Ji, D.;  Qin, Z.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Clinical Characterization Of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers 会议论文
作者:  Liu, Z.;  Hu, Y.;  Wu, L.;  Cao, J.;  Yang, Z.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
Pamiparib, a novel PARP 1/2 inhibitor, monotherapy for gBRCAm patients with recurrent ovarian, fallopian, and primary peritoneal cancer: An open-label, multicenter, phase II trial in China 会议论文
作者:  Wu, X.;  Wang, J.;  Zhou, Q.;  Gu, T.;  Zhang, K.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
Positive effects of hydrogen-water bathing in patients of psoriasis and parapsoriasis en plaques 会议论文
作者:  Zhu, Q.;  Wu, Y.;  Li, Y.;  Chen, Z.;  Wang, L.
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
Effect of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy on Nutritional Status in Locoregionally Advanced Nasopharyngeal Carcinoma Patients: A Prospective Observational Study 会议论文
作者:  Miao, J.;  Hu, C.;  Lin, S.;  Chen, X.;  Chen, Y.
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC) 会议论文
作者:  Wu, Y.;  Chang, J.;  Zhang, L.;  Tu, H.;  Wu, L.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace